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N-methyl-D-aspartate (NMDA) receptors constitute
a major subtype of glutamate receptors at extra-
synaptic sites that link multiple intracellular cata-
bolic processes responsible for irreversible neuronal
death. Here, we report that cerebral ischemia recruits
death-associated protein kinase 1 (DAPK1) into the
NMDA receptor NR2B protein complex in the cortex
of adult mice. DAPK1 directly binds with the NMDA
receptor NR2B C-terminal tail consisting of amino
acid 1292-1304 (NR2BCT). A constitutively active
DAPK1 phosphorylates NR2B subunit at Ser-1303
and in turn enhances the NR1/NR2B receptor chan-
nel conductance. Genetic deletion of DAPK1 or
administration of NR2BCT that uncouples an acti-
vated DAPK1 from an NMDA receptor NR2B subunit
in vivo in mice blocks injurious Ca2+ influx through
NMDA receptor channels at extrasynaptic sites and
protects neurons against cerebral ischemic insults.
Thus, DAPK1 physically and functionally interacts
with the NMDA receptor NR2B subunit at extra-
synaptic sites and this interaction acts as a central
mediator for stroke damage.
INTRODUCTION
Glutamate is the major excitatory transmitter in the mammalian
central nervous system (CNS) and plays an essential role in
neural development, excitatory synaptic transmission, and plas-
ticity (Greengard, 2001). Immediately following ischemia,
however, glutamate accumulates at synapses (Drejer et al.,
1985; Rossi et al., 2000), resulting in extensive stimulation of
its receptors that can eventually be toxic to neurons (Lipton,
2006; Lo et al., 2003). Glutamate activates three classes of iono-222 Cell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc.phore-linked postsynaptic receptors, namely N-methyl-D-
aspartate (NMDA) and a-amino-3-hydroxy-5-methyl-4-isoxa-
zole propionic acid (AMPA) and kainate receptors. NMDA
receptor toxicity is dependent on extracellular Ca2+, and reflects
a large amount of Ca2+ influx directly through the receptor-gated
ion channels (Simon et al., 1984; for review, see Lipton, 2006; Lo
et al., 2003). As most AMPA receptor channels have poor Ca2+
permeability, injury may result primarily from indirect Ca2+ entry
through voltage-gated Ca2+ channels, Ca2+-permeable acid-
sensing ion channels (Xiong et al., 2004), and possibly via
a cleavage of Na+/Ca2+ exchangers (Bano et al., 2005). Ca2+
overload triggers several downstream lethal reactions including
nitrosative stress (Aarts et al., 2003; Uehara et al., 2006), oxida-
tive stress (Kinouchi et al., 1991) and mitochondrial dysfunction
(Krajewski et al., 1999; Fiskum et al., 1999). Thus, over-stimula-
tion of glutamate receptors can be considered as a primary intra-
cellular event that induces neuronal death in stroke.
NMDA receptors constitute the major subtype of glutamate
receptors, and normally participate in rapid excitatory synaptic
transmission. To date, a variety of NMDA receptor subunit pro-
teins (NR1, NR2A–D) have been cloned (Madden, 2002). Native
NMDA receptors appear to be heteroligomeric complexes con-
sisting of an essential NR1 subunit and one or more regulatory
NR2 subunits (NR2A–D) and possibly the more recently identi-
fied NR3 subunit (Chatterton et al., 2002). Since the NR2C-
(and possibly NR2D-) containing receptors have very low proba-
bility for their channel opening (Sprengel et al., 1998), both
NR2A- and NR2B-containing NMDA receptors are considered
as the main types of functional NMDA receptor channels in
CNS neurons (Madden, 2002). Activation of NMDA receptors
requires two coincident events: 1) binding to the coagonists of
glutamate and glycine, and 2) simultaneous membrane depolar-
ization, which removes the Mg2+ blockade of the channel pore,
leading to the influx of Ca2+. Under physiological conditions,
the entrance of Ca2+ produces partial inhibition of NMDA
receptors via Ca2+-dependent inactivation, thereby preventing
the intracellular Ca2+ overload (Krupp et al., 1999). Under
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Figure 1. Ischemia Recruits DAPK1 into
NMDA Receptor Complex
(A) The immune-precipitates with nonspecific IgG
(N.S. IgG), or antibody against NMDA receptor
NR2B subunit (anti-NR2B) in the membrane
extracts (5 mg proteins) from the cortex of mice
2 hr after operation for sham or MCAO (Ischemia)
were stained with Coomassie blue.
(B) Base peak chromatogram from trypsin-
digested products of a selected protein band
(arrow head in [A]).
(C and D) The membrane extracts (1 mg proteins)
from the cortex of mice 2 hr after sham (lane 1) or
MCAO (lane 2) were precipitated with nonspecific
IgG (IgG) or anti-NR2B (C) or anti-DAPK1 (D) and
probed with anti-DAPK1, anti-NR1, anti-PSD95
or anti-NR2B. Input: 20 mg of protein was loaded
in each lane except the PSD95 lane, in which
10 mg proteins were loaded.
(E–G) DAPK1+/+ (E) and DAPK1/ (G) cultured
neurons were stained with anti-DAPK1 (red) and
anti-NR2B (green). A high magnified image (F)
from a selected area in (E). In panels A–G, similar
results were observed in each of the four experi-
ments.
See also Figure S1.pathological conditions, however, this negative feedback in Ca2+
regulation of NMDA receptors is disabled, resulting in excessive
Ca2+ influx through the receptor channels (Wang et al., 2003a).
Ca2+ overload triggers multiple intracellular catabolic processes,
and thus induces an irreversible death of neuronal cells in the
brain (for review, see Lipton, 2006; Lo et al., 2003).
Although over stimulation of NMDA receptors contributes to
ischemic neuronal death, blocking them totally could be delete-
rious to animals and humans because targeting these receptors
also blocks the physiological actions of the receptor as well. In
the present study, we report that DAPK1, or death-associated
protein kinase 1, acts as a specific ‘‘cell death signal’’ that
couples NMDA receptor channels at extrasynaptic sites to
ischemic neuronal death. We also demonstrate that uncoupling
of an activated DAPK1 from the NMDA receptor complex
protects against brain damage in stroke without affecting the
physiological actions of the NMDA receptors. Thus, targeting
DAPK1-NMDA receptor interaction can be considered as a prac-
tical strategy for stroke therapy.Cell 140, 222–234RESULTS
Cerebral Ischemia Recruits DAPK1
into NMDA Receptor NR2B Protein
Complex
To explore the cell death signals that are
linked with NMDA receptors in stroke
damage, we used anti-NMDA receptor
NR2B antibodies to precipitate the
NMDA receptor complex in the mem-
brane extracts from the cortex of mice
that had been subjected to focal cerebral
ischemia or sham operation (for details,see Experimental Procedures). The precipitates from both
groups were separated on the SDS-PAGE and stained with
Coomassie blue (Figures 1A and 1B). Compared to the control
group, the additional protein bands on the gel with estimated
size of 66 kDa and 150 kDawere observed in the ischemic group.
We then analyzed the protein components in these bands using
a reverse phase Nano-Liquid Chromatography-Tandem Mass
Spectrometry (NLC/MS) approach. Five peptide sequences:
AEQHEHVAGLLAR,DKSGETALAVAAR,GLFFQQLRPTQNLQPR,
HYLSPQQLR, and RGVSREDIER, were found to match death-
associated protein kinase 1 (DAPK1, see Tables S1 and S2).
We next probed the precipitates with antibody against DAPK1
and confirmed the existence of endogenous DAPK1 in the
NMDA receptor complex (Figure 1C, see also Figure S1). We
also carried out the reciprocal coimmuno-precipitation, in which
anti-DAPK1 was used to precipitate NMDA receptor NR1, NR2B
subunits, and their functional interacting partner PSD-95, and
CaMK-II (Figure 1D). Single neuronal labeling demonstrated a
colocalization of DAPK1 with NMDA receptor NR2B subunits, January 22, 2010 ª2010 Elsevier Inc. 223
–100
–25
Anti-DAPK1
NR2B
CT 
- +     -
sNR2B
CT
- - +
–250
–150
D
Anti-DAPK1
Anti-PSD-95
NR2B
CT 
- - +     -
sNR2B
CT 
- - - +
Input IgG NR2B
Co-IP
–250
–100
–100
–75
NR2B
839-1482
NR2B
1292-1304
A
NR2B
839-1261
NR2B
1261-1292
GST-
NR2B
1305-1482
Anti-Flag
C
N
C
GST-NR2B MutantsB
Anti-GST
–100
–25
–75
–25
Anti-CaMK-II
Figure 2. DAPK1 Directly Binds to NMDA Receptor
NR2B Subunit
(A) Representation illustrates a series of GST fusion
proteins with the NR2B C-terminal mutants. (B) Affinity
binding assay shows that flag-tagged catalytic domain of
DAPK1 binds with GST-NR2B839-1482 (100 kDa) and
GST-NR2B1292-1304 (30 kDa). The blots show anti-Flag
(top) and anti-GST (bottom).
(C) NR2BCT suppresses DAPK1 association with NMDA
receptor NR2B subunit. Membrane extracts (500 mg
proteins) from the forebrain of mice 2 hr after MCAO
were incubated with GST or the GST-NR2BCT
839-1482 in
the presence of 50 mM NR2BCT or sNR2BCT and probed
with anti-DAPK1.
(D)NR2BCTblocksNMDAreceptor associationwithDAPK1
but not with PSD-95.Membrane extractswere precipitated
with nonspecific IgG (IgG) or anti-NR2B in the presence of
50 mM NR2BCT or sNR2BCT and probed with anti-DAPK1,
or anti-PSD-95, or anti-CaMK-IIa. Input: 50 mg of protein
was loaded in each lane. In (B)–(D), similar results were
observed in each of the four experiments.at the post-synaptic spines (Figures 1E–1G). Thus, DAPK1 is
physically associated with NMDA receptors.
To identify a direct binding region of NMDA receptor NR2B
subunit with DAPK1, we generated a series of NMDA receptor
NR2B C-terminal deletion mutants fused with glutathione-
S-transferase (GST, Figure 2A). We found that only the
NR2B1292-1304 fragment was capable of binding with DAPK1
(Figure 2B). The NR2B1292-1304 fragment contains a consensus
binding motif (R/K[R/K][R/KXXRXXSX]) of DAPK1 with only one
mismatch residue at asparagine-1296 (Schumacher and Scha-
vocky, 2004). We subsequently synthesized a NR2B C-terminal
tail peptide of 1292KKNRNKLRRQHSY1304 (NR2BCT). Application
of 50 mM NR2BCT uncoupled an activated DAPK1 from NMDA
receptor NR2B protein complex (Figure 2C), but it did not affect
the association of PSD-95 or CaMK-II with the NMDA receptor
NR2B subunit (Figure 2D).
DAPK1 Activation Enhances the NR1/NR2B Channel
Conductance
Having determined a binding domain of DAPK1 with the NMDA
receptor NR2B subunit, we then examinedwhether DAPK1 func-
tionally regulates NMDA receptor channel activity. We coex-
pressed the NR1/NR2B receptors with a constitutively active
DAPK1 (cDAPK1), or the wild-type DAPK1 (wDAPK1) in
HEK293 cells. We found that cDAPK1 increased the peak ampli-
tude of the recombinant NR1/NR2B receptor currents (Fig-
ure 3A), but not the NR1/NR2A receptor currents (Figure 3B),
at a range of holding potentials from 100 to +100 mV. Since
the decay time constants and the reversal potentials were
not changed (Figure 3A), cDAPK1 specifically increases the
recombinant NR1/NR2B receptor channel conductance. To
determine whether enhancement of NR1/NR2B receptor cur-
rents is mediated directly by DAPK1-NR2B interaction, we
made use of NR2B subunit C-terminal peptide, NR2BCT, at a
concentration of 10, 25, or 50 mM, which was diffused directly
into the recording cells via path electrode (Figure 3C). After
a 10 min diffusion of 50 mM NR2BCT, the peak amplitude of the
whole-cell currents decreased by 0.56 ± 0.086 of the baseline
(mean ± standard error of the mean [SEM], Figure 3C). A peptide224 Cell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc.with the same amino acid composition but in random order
scrambled NR2BCT (sNR2BCT) served as control, and did not
reduce the recombinant NR1/NR2B receptor currents (0.98 ±
0.11 of the baseline, mean ± SEM). Whole-cell currents in
HEK293 cells coexpressing NR1/NR2B with wDAPK1 were not
affected by 50 mM NR2BCT (Figure 3D). Thus, enhancement of
the recombinant NR1/NR2B receptor channel conductance is
mediated by activated DAPK1 binding with NR2B subunit.
DAPK1 Activation Phosphorylates NR2B Subunit
at Ser-1303
We next examined whether an activated DAPK1 phosphorylates
NR2B subunit at Ser-1303, (Figure 3E), a residue corresponding
to a phosphorylation site (KXXRXXSX) of DAPK1 (Schumacher
and Schavocky, 2004). We coexpressed wDAPK1 or cDAPK1
in HEK293 cells with the recombinant NR1/NR2B or the
mutant NR1/NR2BS1303A receptors. In the mutant NR2BS1303A,
a Ser-1303 residue was replaced with an alanine (A). The levels
of phosphorylation at Ser-1303 (pS1303) were measured using
antibody against the pS1303 (anti-pS1303). The anti-pS1303
recognized the recombinant wide NR2B subunit, but not with
the mutant NR2BS1303A, demonstrating the specificity of anti-
pS1303 reaction (Figure 3E). To determine whether phosphoryla-
tion of NR2B at Ser-1303 is sufficient to modulate the NR1/
NR2B receptor channel activity, whole-cell currents were
recorded from HEK293 cells coexpressing the NR1/NR2B or
the mutant NR1/NR2BS1303A with wDAPK1 (Figure 3F) or
cDAPK1 (Figure 3G). We found that cDAPK1 increased the peak
amplitude of the recombinant NR1/NR2B receptor currents, but
not the mutant NR1/NR2BS1303A receptor currents, at a range
of holding potentials from 80 to +80 mV (Figure 3G). Thus,
an activated DAPK1 enhances NR1/NR2B receptor channel
conductance by phosphorylating NR2B subunit at Ser-1303.
Generation of Null Mutant Mice Lacking the DAPK1
Gene
To determine whether an activated DAPK1 physically and func-
tionally interacts with synaptic NMDA receptor NR2B subunit
in vivo, we generated null mutant mice with deficiency in
expression of DAPK1 (DAPK1/ mice). b-gal, a marker for
DAPK1 deletion, was observed throughout the brain of the
DAPK1/ mice, including the cortex and hippocampus (Fig-
ure 4A). RT-PCR and western blot analysis revealed undetect-
able levels of DAPK1 mRNA (Figure 4B) and proteins (Figure 4C)
in the DAPK1/ mice. No difference of DAPK2 and DAPK3
proteins was observed between DAPK1/ and DAPK1+/+
mice (Figure 4D).
We next surveyed several synaptic proteins, including AMPA
receptor subunits GluR1 and GluR2, and NMDA receptor
subunits NR1, NR2A, and NR2B and PSD-95 (Figure 4D). We
confirmed that genetic deletion of DAPK1 does not alter the
overall synaptic protein compositions in the brain. We next
examined synaptic transmission in the CA1 hippocampus.
We analyzed excitatory post-synaptic currents (EPSCs). By plot-
ting the mean amplitude of EPSCs in CA1 pyramidal neurons
versus the stimulus intensities, we determined that the input-
output curves were identical between genotypes (Figure 4E).
The current-voltage (I-V) relations of AMPA receptor- and
NMDA receptor-mediated EPSCs (EPSCsAMPA, Figure 4F, and
EPSCsNMDA, Figure 4G), and the induction of long-term potenti-
ation (LTP, Figure 4H), also were not affected in the DAPK1/
mice.
DAPK1 Activation Enhances Extrasynaptic NMDA
Receptor Channel Activity
Having demonstrated that genetic deletion of DAPK1 did not
alter NMDA receptor physiology, we next examined the func-
tional impacts of DAPK1 deletion in NMDA receptor toxicity.
First, we treated the cortical neurons from DAPK1/ and
DAPK1+/+ mice with oxygen/glucose deprivation (OGD). Cata-
lytic activity of DAPK1 was measured using immune-complex
kinase assay with myosin light chain (MLC) as an endogenous
substrate. We found that enzymatic activity of DAPK1 began to
increase 5 min after OGD, and reached a peak 30 min later (Fig-
ure 5A). Activation of DAPK1 was maintained for over 30 min
after OGD was washed out (Figures 5A and 5B). Activation of
DAPK1 was not affected by applying AMPA receptor antagonist
(10 mMCNQX), but was completely eliminated either by applying
NMDA receptor antagonist (50 mMD-AP5) or by removing extra-
cellular Ca2+ (Ca2+-free, Figure 5C). Catalytic activity of DAPK1 is
controlled by its autophosphorylation at serine-308 (pS308);
dephosphorylation of pS308 allows DAPK1 to bind with CaM,
thereby activating DAPK1 (Shohat et al., 2001). Consistent with
this previous report, we found that DAPK1 became dephos-
phorylated at pS308 in cortical neurons following OGD exposure.
Significantly, we showed that dephosphorylation of DAPK1 at
pS308 was catalyzed by calcineurin (CaN, see also Figure S2).
Next, we investigated the functional impacts of an activated
DAPK1 on NMDA receptor channels in vivo. We challenged the
cortical neurons with OGD or with 50 mM NMDA/10 mM glycine
for 30 min to activate an endogenous DAPK1. Western blots of
the precipitates showed that the levels of pS1303, but not the
NR2B protein, were elevated in DAPK1+/+ cortical neurons (Fig-
ure 5D). An increase of pS1303 in response to OGD (Figure 5D) or
to NMDA challenging (Figures 5E and 5F) was not observed in
DAPK1/ neurons (Figure 5E). Thus, an activated DAPK1 is
a response to phosphorylation of NR2B subunit at Ser-1303.To determine whether an increase of the pS1303 level by an
activated DAPK1 enhances synaptic NMDA receptor channel
activity, we performed fluorescence ratio-metric Ca2+ image
combined with whole-cell patch clamp recordings. We found
that Ca2+ influx through synaptic NMDA receptor channels
were not affected by an activated DAPK1; the peak amplitudes
of Ca2+ transients were identical between groups (Figure 5G).
Since DAPK1 enhances the channel conductance of the recom-
binant NR1/NR2B receptors, which are known to be expressed
predominantly in the extrasynaptic sites (Tovar and Westbrook,
1999; Brickley et al., 2003), we reasoned that an activated
DAPK1 may functionally interact with extrasynaptic NMDA
receptors. To test this possibility, we recorded the extrasynaptic
NMDA receptor-mediated currents (eNMDAc) and Ca2+ tran-
sients by blocking synaptic NMDA receptor channels using
MK-801 trapping protocol (for details see Experimental Proce-
dure). We treated the single cortical neurons with OGD or
50 mM NMDA for 30 min to activate endogenous DAPK1. After
a 30 min recovery period, the whole-cell currents and Ca2+ tran-
sientswere recorded (Figure5H). Agreater amplitudeof eNMDAc
and Ca2+ transients was observed in DAPK1+/+ neurons,
compared to controls. Thus, an activated DAPK1 increases
Ca2+ influx through extrasynaptic NMDA receptor channels.
DAPK1 Deletion Protects against Cerebral Ischemic
Neuronal Death
We next examined whether ischemic insult is mediated by
DAPK1 induction of injurious Ca2+ influx through extrasynaptic
NMDA receptor channels. We challenged cortical cultures with
OGD or 50 mM NMDA/10 mM glycine for 60 min. 24 hr after
washout cell death was examined. Propidium iodide (PI) staining
showed that genetic deletion of the DAPK1 gene sufficiently pro-
tected against the insults induced by either OGD or NMDA chal-
lenging (Figures 6A and 6B). Next, we subjected the DAPK1/
and DAPK1+/+ mice with transient global ischemia by occlusion
of the common carotid artery for 20 min. Six days after reperfu-
sion, brain sections were stained with Fluoro-Jade (FJ), a marker
for degenerating neurons. An unbiased stereological analysis
was used to count the FJ-labeled (FJ+) neurons in the CA1
area of the hippocampus, the layer 3 of the cortex, and the stria-
tum. These three groups of neurons were examined because
they are known to be vulnerable to transient global ischemic
insult (Simon et al., 1984; Pellegrini-Giampietro et al., 1997;
Wang et al., 2003a; Liu et al., 2004; Peng et al., 2006). In the
DAPK1+/+ mice, the majority of these neurons had degenerated
(275 ± 32 FJ+ cells / 0.2 mm3 in the cortex, 169 ± 26 FJ+ cells /
0.2 mm3 in the striatum, and 361 ± 38 FJ+ cell/0.2 mm3 in the
CA1 region, n = 7 mice, Figures 6C–6E). This severe neuronal
injury was observed only in the DAPK+/+ mice; markedly less
damage was detected in the DAPK/ mice (81 ± 14 FJ+ cells /
0.2 mm3 in the cortex, 59 ± 9 FJ+ cells / 0.2 mm3 in the striatum,
and 92 ± 7 FJ+ cell/0.2 mm3 in the CA1 region, n = 6 mice,
p < 0.01, Figure 6E). We also operated on mice to induce focal
cerebral ischemia with middle cerebral artery occlusion
(MCAO) for 60 min or 120 min. After 24 hr reperfusion, the brain
infarction was analyzed using TTC staining. We found that the
DAPK/ mice had a dramatic reduction of the brain infarction
(14.2 ± 2.1 mm3 at 60 min MCAO; 29.6 ± 3.3 mm3 at 120 minCell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc. 225
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Figure 3. DAPK1 Phosphorylates NR2B at Ser-1303 and Increase the Channel Conductance
(A) Whole-cell currents at holding potential of30mV in HEK293 cells coexpressing NR1/NR2B receptors without (control) or with wild-type DAPK1 (wDAPK1) or
constitutively active DAPK1 (cDAPK1). Bar graph shows decay time constants of the receptor currents fitted with two exponential components with tfast (75%,
filled bars) and tslow (25%, open bars). The peak currents were plotted against holding potentials without (open circles) or with expression of wDAPK1 (triangles,
n = 21 cells) or cDAPK1 (filled circles, n = 22 cells).
(B) Expression of cDAPK1 does not alter NR2A receptor currents. Whole-cell currents are at a holding potential of60mV in HEK293 cells coexpressing the NR1/
NR2A receptors without (control) or with wDAPK1 or cDAPK1. The peak currents were plotted against holding potentials without (open circles, n = 18 cells) or with
expression of wDAPK1 (filled circles, n = 18 cells) or cDAPK1 (triangles, n = 18 cells).
(C and D) NR2BCT antagonizes the cDAPK1-NR2B interaction. The averaged whole-cell currents are plotted against time with the intracellular perfusion of
10 (filled circles), 25 (open triangles) or 50 mM NR2BCT (open circles) or 50 mM sNR2BCT (filled triangles) in HEK293 cells coexpressing NR1/NR2B with cDAPK1
(C). In recordings from HEK293 cells coexpressing NR1/NR2B with wDAPK1 (D), 50 mMNR2BCT (open circles) or sNR2BCT (filled circles) were applied. The peak
currents were normalized to baseline (defined as 1.0, n = 22 cell per group, *p < 0.01). Horizontal above the graphs indicate the period of peptide administration.
Arrows indicate the time of application of 1 ms pulse of 500 mM glutamate.
(E) Illustration (top) shows that DAPK1 targets to NR2B C-terminal at Ser-1303. Bottom: the NR1/NR2B (lane: NR2B) or the mutant NR1/NR2BS1303A (lane:
NR2BS1303A) that were coexpressed with wDAPK1 or cDAPK1 in HEK293 cells were subjected to western blot with anti-pS1303 or anti-NR2B. Similar results
were observed in each of four experiments.
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MCAO, n = 11 mice/group), compared to DAPK1+/+ mice (34.3 ±
4.6 mm3 at 60 min MCAO; 52.9 ± 6.2 mm3 at 120 min MCAO;
n = 11 mice/group, p < 0.001, Figures 6F and 6G). This reduction
of the brain infarction was associated with improvement of the
neurological scores in DAPK1/ mice (p < 0.01, n = 11 mice
per group, Figure 6G). Thus, DAPK1 can be considered as
a primary mediator in brain damage of stroke.
Treatment of Stroke by Uncoupling DAPK1 from NMDA
Receptor NR2B Subunit
DAPK1 physically and functionally interacts with the NMDA
receptor NR2B subunit, and this interaction might act as an
essential intracellular event in stroke damage. To investigate
this, we examined whether blocking DAPK1-NR2B interaction
achieves the therapeutic effects in mouse models with stroke.
To do so, we generated cell membrane permeable NR2BCT
peptide by fusing the NR2BCT to the cell-membrane transduc-
tion domain of the HIV-1 Tat protein (Tat-NR2BCT, for details
see Experimental Procedures). Western blots of the precipitates
revealed that application of Tat-NR2BCT sufficiently uncoupled
an activated DAPK1 from the NMDA receptor NR2B subunit
complex (Figure 7A). Although Tat-NR2BCT did not affect the
catalytic activity of DAPK1 (Figure 7A), it completely blocked; [1])
an association between an activated DAPK1 and the NMDA
receptor NR2B subunit; [2]) NR2B phosphorylation at Ser-1303
(Figure 7B, see also Figure S3); and [3]) Ca2+ influx through
NMDA receptor channels at extrasynaptic sites (Figure 7C).
We next operated on mice with MCAO for 60 min, and
analyzed enzymatic activity of DAPK1. Our data revealed that
DAPK1 in the forebrain of mice became activated 60 min, and
reached a peak 120 min after reperfusion. Activation of DAPK1
was closely associated with phosphorylation of NR2B subunit
at Ser-1303 (see also Figure S3). Blots of the anti-NR1 precipi-
tates in the forebrain extracts showed Tat-NR2BCT at a dose of
10 mg/kg that did not alter the catalytic activity of DAPK1, but
that sufficiently uncoupled an activated DAPK1 from NMDA
receptor NR2B complex (see also Figure S3). By measuring
the cerebral infarction 24 hr after MCAO operation using TTC
staining, we found that the total infarction volume in the Tat-
NR2BCT -treated mice was reduced to 15.2 ± 1.2 mm
3,
compared to 37.9 ± 4.3 mm3 in control, in which mice were
injected with Tat-sNR2BCT (mean ± SEM, n = 11 mice per group,
ANOVA, F = 12.98, p < 0.001, Figure 7D). Furthermore, a signifi-
cant reduction of the cerebral infarction was also observed
even when Tat-NR2BCT (10 mg/kg, i.v.) was administered
60min after MCAO operation (19.3 ± 1.9 mm3 in the Tat-NR2BCT
post-treatment, and 36.1 ± 3.7 mm3 in Tat-sNR2BCT-post-
treatment, n = 8 mice/group, Figure 7D). A reduction of brain
infarction was closely associated with improved neurological
behaviors (Figure 7D). Together, our data demonstrate that
DAPK1 physically and functionally interacts with the NMDA
receptor NR2B subunit and that this interaction mediates stroke
damage.(F and G) Whole-cell currents are recorded at holding potential of 30 mV in HEK
with wDAPK1(F) or cDAPK1 (G). The peak currents were plotted against hold
n = 23 cells) or the mutant NR1/NR2BS1303A (open circles, n = 21 cells).
In panels A–G, data are mean ± SEM, *p < 0.01.DISCUSSION
NMDA receptor NR2B subunits have recently become the major
focus of studies in the treatment of stroke because of their
unique features (Hardingham et al., 2002; Simpkins et al.,
2003; Liu et al., 2007). First, in the adult CNS neurons NMDA
receptor NR2B subunits are localized predominantly at extra-
synaptic sites (Tovar andWestbrook, 1999; Brickley et al., 2003).
This feature enables the receptor to detect extrasynaptic gluta-
mate spillover in the brain during ischemic insults (Drejer et al.,
1985; Rossi et al., 2000). Second, extrasynaptic NMDA recep-
tors are reported to link the specific signals that induce neuronal
death in ischemia (Finkbeiner, 2000; Hardingham et al., 2002,
Takasu et al., 2002; Liu et al., 2007). However, it is now believed
that NMDA receptor NR2B subunits may be also combined with
NR1/NR2A subunits to form NR1/NR2A/NR2B complex recep-
tors at synapses (Thomas et al., 2006). Thus, using NMDA
receptor NR2B subunit antagonists for selectively inhibiting
extra-synaptic NMDA receptors still could be problematic.
Alternatively, recent studies have focused on NMDA receptor
NR2B subunit downstream cell death signaling via interaction
with PSD-95 (Aarts et al., 2002). Disturbing NR2B-PSD-95
interaction by expression of a peptide fragment of the NR2B
C-terminal tail (KLSSIESDV) uncouples neuronal nitric synthase
(nNOS) activation, protecting cerebral ischemic infarction in
adult rats (Aarts et al., 2002). This finding suggests that blocking
NR2B-PSD-95 interaction would be able to eliminate NMDA
receptor NR2B subunit toxicity. However, this strategy has
been challenged by its parallel inhibition of synaptic plasticity
(El-Husseini et al., 2002). Also, some other studies indicated
that inhibition of PSD-95 increased brain damage in stroke (Gar-
doni et al., 2002).
Multiple intracellular signals are able to regulate NMDA
receptor channel activity (Ghosh, 2002) and induce NMDA
receptor-dependent cell death (Simon et al., 1984; Wang et al.,
1999). Some including calcineurin (CaN) (Wang et al., 1999),
Ca2+/CaM-activated protein kinase II (CaMK-II) (Mabuchi et al.,
2001), protein kinase C (Sun et al., 2008), cycline-dependetn
kinase 5 (Cdk5) (Wang et al., 2003a), tyrosine kinases (Khanna
et al., 2007), and nNOS (Eliasson et al., 1999), however, also
control the physiological processes of gene expression, as well
as synaptic plasticity (Ghosh, 2002; Salter and Kalia, 2004),
and thus are not promising targets for stroke therapy.
DAPK1 belongs to a Ca2+/CaM-dependent protein kinase
family, and comprises a kinase domain, a CaM-binding motif,
eight ankyrin repeats, and a death domain (for reviews, see Bialik
and Kimchi, 2006; Van Eldik, 2002; Velentza et al., 2001). The
kinase domain resides at the amino terminus and precedes the
CaM-binding motif, which consists of a CaM binding site and
an autoinhibitory region. CaM binding to the CaM binding site
induces a conformation change. Ths conformation change is
known to relieve the steric block of the active site by the autoin-
hibitory region (Van Eldik, 2002), and possibly leads to an293 cells coexpressing NR1/NR2B or the mutant NR1/NR2BS1303A receptors
ing potentials in HEK293 cells with expression of NR1/NR2B (filled circles,
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Figure 4. The Mutant Mice Lacking the DAPK1 Gene Have Normal Synaptic Transmission
(A) A promoterless gene trapping vector fused into a reporter gene (b-geo) was inserted into the first intron of DAPK1. Staining on a sagittal brain section from an
adult DAPK1/ mouse shows the b-geo protein in the cortex and hippocampus.
(B and C) Representatives show the RT-PCR and western blots of DAPK1 mRNA (B) and proteins (C) in the brain of the homozygous (DAPK1/), heterozygous
(DAPK1-/+) and their wild-type littermates (DAPK1+/+) mice.
(D) Blots show DAPK2, DAPK3, and synaptic proteins in the brains of DAPK1+/+, DAPK1+/, and DAPK1/ mice. The intensities of the blots (bar graph) were
normalized to the respective blots in DAPK1+/+ mice (defined as 1.0). Data are mean ± SEM (n = 4 mice/group).
(E) The DAPK1/ mice have normal input-output responses. The EPSCs (top) were recorded from CA1 pyramidal neurons at holding potential of 70 mV. The
mean amplitudes from DAPK1+/+ (open circles) and DAPK1/ (filled circles) mice, as summarized in graph (bottom), were plotted against the intensities of stim-
ulus. Data are mean ± SEM (n = 8 cells/4 mice per group).
(F and H) Sweeps (top) and the current-voltage relations of the excitatory post-synaptic currents (EPSCs) mediated by AMPA (EPSCsAMPA, F) and the NMDA
receptors (EPSCsNMDA, G) at holding potentials of80,40, 0 +20, or +40 mV were recorded in CA1 neurons from DAPK1+/+ (open circles) and DAPK1/ (filled
circles) mice. Data are mean ± SEM (n = 12 cells/6 mice per group).
(H) A plot represents the normalized peak amplitude of the EPSCsAMPA in CA1 neurons fromDAPK1
+/+ (open circles) andDAPK1/mice (filled circles). The traces
above the graph are averages of three sweeps taken at the time points indicated by the letter above the x axis. Arrow indicates the time of tetanus. Data are
mean ± SEM (n = 12 cell/6 mice per group).activated DAPK1 binding with the NMDA receptor NR2B
subunit. Consistent with this idea, our data revealed that activa-
tion of DAPK1 following ischemic insult phosphorylates the228 Cell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc.NMDA receptor NR2B subunit at Ser-1303. Interestingly, the
NR2B at Ser-1303 is the same residue as that catalyzed by
CaMK-II (Omkumar et al., 1996). Thus, DAPK1 may have
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Figure 5. Activation of DAPK1 Induces Ca2+ Influx through Extrasynaptic NMDA Receptors
(A and B) DAPK1+/+ (A) and DAPK1/ (B) cortical neurons were exposed to OGD for 0, 5, 15, or 30 min. Immediately after OGD (OGD) or 30 min after OGD
washout (w), DAPK1 complex was precipitated and blotted with anti-pMLC or anti-DAPK1. The intensities of the anti-pMLC (filled bars) and anti-DAPK1
(open bars) blots were normalized to their respective signals at 0 min OGD (defined as 1.0, n = 16).
(C) DAPK1+/+ neurons were treatedwith saline (lane 1 and lane 2), 10 mMCNQX (lane 3), 50 mMD-AP5 (lane 4), or Ca2+-free (lane 5) for 10min, and then challenged
with sham control (lane 1) or with OGD (lane 2 through lane 5) for 30 min. DAPK1 complex was then precipitated and blotted with anti-pMLC or anti-DAPK1. The
ratio of anti-pMLC versus anti-DAPK1 blots were calculated (n = 12 cultures/4 mice) and summarized in bar graph.
(D) DAPK1+/+ (lane 1) and DAPK1/ (lane 2) neurons were exposed to shame or OGD for 30 min. NMDA receptor complex was precipitated with anti-NR1 and
blotted with anti-pS1303 or anti-NR2B. The intensities of blots were normalized to their respective controls (defined as 1.0, n = 12 cultures/4 mice).
(E and F) NMDA treatment activates DAPK1 (E) and increases the levels of pS1303 in cortical neurons (F). DAPK1+/+ (lane 1) and DAPK1/ (lane 2) cortical neurons
were challenged with saline, 10 mMbicuculline (Bic), or 50 mMNMDA/10 mMglycine for 30min. Endogenous DAPK1 and NMDA receptor protein complexes were
then precipitated and blotted, as indicated. The intensities of the blots were normalized to their respective controls (defined as 1.0), and summarized in bar graphs
(n = 12 cultures/4 mice).
(G) Images are taken at the time points indicated by the numbers above the traces from single DAPK1+/+ neuron with pre-OGD (Red) or sham (Green). Ca2+ tran-
sients were evoked by 30 mM Bic and 10 mM nifedipine (Nif) and blocked by 10 mM MK-801.
(H) Cortical neurons were exposed to control, OGD, 10 mM Bic, or 50 mM NMDA/10 mM glycine for 30 min. 30 min after washout Ca2+ transients and whole-cell
currents (eNMDAc) were evoked by a 5-ms pulse of 100 mM NMDA/10 mM glycine. Data (*p < 0.01) in bar graphs are DAPK1+/+ (red bars) and DAPK1/ (green
bars) neurons (n = 22 cells per group).
In panels A–H, data in bar graphs are mean ± SEM. See also Figure S2.
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Figure 6. Genetic Deletion of DAPK1 Protects against Ischemic Neuronal Death
(A) DAPK1 deletion protects cortical neurons against OGD insult. DAPK1+/+ andDAPK1/ cortical cells were challengedwith OGD for 60min. 24 hr after washout
the cultures were stained with propidium iodide (PI, red), and single DIC or double DIC/PI images were collected. (B) Bar graph summarizes the percentage of PI+
cells (n = 12 cultures). Data are mean ± SEM.
(C–E) Images of cortex, striatum and the hippocampus fromDAPK1/ (C) and DAPK1+/+ (D) mice that were stained with Fluoro-Jade 6 days after transient global
ischemia. Bar graph (E) shows summarized Fluoro-Jade-labeled cells (n = 7). Data are mean ± SEM.
(F and G) Images of the brain sections (1.0 mm, F) from DAPK1+/+ and DAPK1/ mice 24 hr after operation for 60 min or 120 min MCAO that were stained with
TTC. Bar graphs show the infarct volume and neurological scores (N.S.). Data are mean ± SEM (*p < 0.01).a functional analogous to that of CaMK-II. CaMK-II is one of the
most abundant Ca2+/CaM-dependent enzymes in the central
neurons and participates in synaptic plasticity (Lisman et al.,
2002) as well as in the cellular events responsible for ischemic
neuronal death (Waxham et al., 1996). However, CaMK-II was230 Cell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc.found to become inactivated in the brain in response to ischemic
insults (Hanson et al., 1994; Waxham et al., 1996; Petersen et al.,
2003). Inhibition of CaMK-II enhances the vulnerability of brain
cells to stroke damage (Waxham et al., 1996). In this context,
CaMK-II can be viewed as a neuronal survival mediator. Thus,
N
.
S
.
0.0
2.5
5.0
C
a
2
+
 
(
n
M
)
0
500
1000
e
N
M
D
A
c
 
(
p
A
)
0
500
1000
p
S
1
3
0
3
 
L
e
v
e
l
s
0
1
2
3
I
n
f
a
r
c
t
i
o
n
 
(
m
m
3
)
0
25
50
D
1                            2
Before        After
1             2
Before      After
**
50 µm
C
200 ms
1
0
0
n
M
1
0
0
p
A
A Anti-NR2B
DAPK1
IP
Input
Anti-pMLC
Anti-DAPK1
Control OGD
1 2 1    2
B
1    2     1     2     1     2     1    2  
Anti-pS
1303
Anti-NR2B
30 min
Tat-NR2B
CT                
OGD pS
1303
30 min
Ctr OGD        Bic NMDA
Tat-NR2B
CT
Tat-sNR2B
CT
* *
30 min 30 min 30 min
Tat-NR2B
CT    
OGD Wash Recordings
Control    OGD     NMDA
* *
* *
Ctr OGD          Bic NMDA
1           2
Before      After
**
Figure 7. Inhibition of DAPK1-NMDA Receptor Interaction Protects against Stroke Damage
(A) Tat-NR2BCT treatment disturbs the DAPK1-NMDA receptor association without affecting DAPK1 activity. DAPK1
+/+ cortical neurons were treated with 50 mM
Tat-NR2BCT or Tat-sNR2BCT or saline for 30 min and exposed to OGD for 30 min. NMDA receptor complex was precipitated with anti-NR2B (top) or anti-DAPK1
(bottom) and blotted with anti-DAPK1 or anti-pMLC, as indicated.
(B) DAPK1+/+ cortical neurons were treated with 50 mM Tat-sNR2BCT (lane 1) or Tat-NR2BCT (lane 2) for 30 min and were then exposed to control, OGD, 10 mM
bicuculline (Bic), or 50 mMNMDA/10 mM glycine for 30 min. Anti-NR1 precipitates were blotted with anti-pS1303 or anti-NR2B, as indicated. Data in bar graph are
mean ± SEM (n = 16 cultures/4 mice, *p < 0.01).
(C) DAPK1+/+ cortical neurons were treated with 50 mM Tat-sNR2BCT (purple traces) or Tat-NR2BCT (green traces) for 30 min and were then exposed to control,
OGD or 50 mM NMDA/10 mM glycine for 30 min. 30 min after washout and Ca2+ transients (top traces) whole-cell currents (bottom traces) were recorded. Data
from Tat-NR2BCT (purple bars) and Tat-sNR2BCT (green bars) in bar graphs are mean ± SEM (n = 16 recordings per group, *p < 0.01).
(D) The adult male DAPK1+/+micewere received a single injection (10mg/kg, i.v.) of Tat-NR2BCT (1) or Tat-sNR2BCT (2) 60min before or 60min afterMCAO (After).
The infarction volume and neurological scores (N.S.) were summarized in the bar graphs (G). Data are mean ± SEM (*p < 0.001).
See also Figure S3.it is unlikely that CaMK-II plays a role in the DAPK1-NR2B inter-
action for ischemic neuronal death.
In the present study, we used Tat-NR2BCT to disrupt the inter-
action between an activated DAPK1 and NMDA receptor NR2B.
Tat-NR2BCT, but not its scrambled control, protected cortical
neurons from NMDA receptor-mediated insults without affecting
catalytic activity of DAPK1 or the NMDA receptor physiology.
Thus, systematic administration of Tat-NR2BCT could serve asan advantage over NMDA receptor antagonists in stroke ther-
apy. Indeed, our data demonstrated that Tat-NR2BCT, even
when it was administered one hour after stroke onset, dramati-
cally reduced brain infarction and improved neurological func-
tions in mice. Thus, targeting the interaction between an acti-
vated DAPK1 and NMDA receptor NR2B could be considered
a promising strategy for the treatment of stroke. It must be noted,
however, that even though we found that Tat-NR2BCT disruptedCell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc. 231
DAPK1-NR2B interaction without interfering with the association
of NR2B with PSD-95 or CaMK-II, we could not exclude the
possibility that inhibition of other binding proteins, rather than
DAPK1 interaction with NMDA receptor NR2B by Tat-NR2BCT,
could be responsible for its neuronal protective effects.
A main question arising from this study is how DAPK1
becomes activated in response to cerebral ischemic insults.
Catalytic activity of DAPK1 is thought to be controlled by its
autophosphorylation at serine-308 (pS308); dephosphorylation
of pS308 allows DAPK1 to bind with CaM, thereby activating
DAPK1 (Shohat et al., 2001). In the present study, we showed
that DAPK1 becomes dephosphorylated at pS308 in cortical
neurons following ischemic insults (Figure S2). We also demon-
strated that dephosphorylation of pS308 in response to ischemic
insults can be eliminated by genetic mutation of calcineurin
(CaN, see also Figure S2). Thus, CaN can be considered as an
upstream activator of DAPK1. It has been known that enzymatic
activity of CaN depends on Ca2+ influx through NMDA receptor
channels (Marshall et al., 2003). Consistent with this previous
report, our data revealed that challenging cortical neurons with
NMDA induced dephosphorylation of pS308 (Figures 5C–5E).
Conversely, application of NMDA receptor antagonist or removal
of extracellular Ca2+ inhibits DAPK1 dephosphorylation at pS308
and inactivates DAPK1 (Figure 5C, see also Figure S2). Thus, the
most parsimonious explanation for our findings is that under
physiological conditions, an initial Ca2+ influx through NMDA
receptor channels produces partial inhibition of NMDA recep-
tors via Ca2+-dependent inactivation, thereby preventing the
intracellular Ca2+ overloading (Krupp et al., 1999). Under patho-
logical conditions such as ischemic insults, however, Ca2+ influx
through NMDA receptor channels activates CaN and in turn
dephosphorylates DAPK1 at pS308, leading to activation of
DAPK1. An activated DAPK1 is recruited into the NMDA receptor
NR2B subunit at extrasynaptic sites and phosphorylates NR2B
subunit at Ser-1303 and subsequently induces injurious Ca2+
influx through NMDA receptor channels, resulting in an irrevers-
ible neuronal death. Thus, DAPK1 can be considered as a
signaling amplifier of NMDA receptors at extrasynaptic sites for
mediating brain damage in stroke.EXPERIMENTAL PROCEDURES
Generation of DAPK1 Null Mutant Mice
The null mutant mice with complete deletion of DAPK1 gene were generated
using a gene-trapping technique. A mouse (strain C57/Bl6) was cloned from
an embryonic stem cell line (IST12766D5; Texas Institute for Genomic Medi-
cine, TIGM), carrying DAPK1 allele disrupted by the insertion of a gene trap
vector with a lacZ (b-galactosidase)-neomycin resistance fusion cassette
(b-gal, Omnibank Vector 76) in the first intron. The insertion site, as denoted
with an asterisk*, was confirmed by genomic sequence, which is available
upon requested. The cloned ES cell was used to generate DAPK1 mutant
mice with a C57/Bl6 background, which were verified by PCR amplification
of the mutant gene in tail DNA from progeny. The homozygous (DAPK1/)
mice were derived by mating heterozygous DAPK1+/mice. The PCR primers
for wild DAPK1 were as follows: sense 50TTGCACAACAGCTACACAGC-300
antisense 50 ATAGTCCCACTACTCAGGTC-30.
Focal Cerebral Ischemia and Transient Global Ischemia
DAPK1 mutant mice were fasted overnight, and anesthetized with 4% halo-
thane andmaintainedwithmechanical ventilation (3.5ml / cycle, 28 cycle /min,232 Cell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc.0.5% halothane in a mixture of 30% O2 and 70% N2O). The blood gas condi-
tions were kept at constant levels throughout the surgery (PO2, 120 ± 10 mm
Hg; PCO2, 35 ± 3 mm Hg), and the rectal and temporal muscle temperatures
were also maintained at 37.5 ± 0.2C and 37.0 ± 0.1C, respectively. Body
temperature was maintained at 37 ± 0.5C with heating pads until the animals
had recovered from surgery. Focal cerebral ischemia was induced by intralu-
minal middle cerebral artery occlusion (MCAO), as described previously. Local
blood flow was monitored using BLF21C Laser Doppler Flow-meter with
LL-M1043 fiber flow-probe (Transonic System Inc, New York), as described
before (Wang et al., 2003a; Liu et al., 2004; Peng et al., 2006, see also
Extended Experimental Procedures).
Administration of Tat-NR2BCT
Mice were intravenously (i.v.) administered with 10 mg/kg Tat-NR2BCT (Tat-
KKNRNKLRRQHSY) or Tat-sNR2BCT (Tat-NRRRNSKLQHKKY) 60 min before
or after MCAO operation. To test whether the Tat-peptide could be delivered
into the brain, the Tat-NR2NCT-fluorescein isothiocyanate (FITC, 10 mg/kg,
i.v.) was injected. 30 min after the injection, the brain sections (30 mm) were
imaged under the Axio Observer 200 Apotome microscope (data not shown).
For the electrophysiological recordings, 50 mM NR2BCT or sNR2BCT was
applied directly into the recording cells via patch electrode. A dose of
10mg/kg tat peptide or 50 mMNR2BCT peptide was chosen because we found
they did not alter DAPK1 activity but uncoupled an activated DAPK1 from
NMDA receptor complex. The peptides with 99% purity were synthesized by
AnaSpec (San Jose, CA) and Peptide 2.0, Inc (Chantilly, VA), respectively.
The peptides were numbered and the experimenters were unaware of which
onewas applied in all experiments.
Whole-Cell Patch Clamp Recordings
Hippocampal slices (300mm)were prepared frommice as previously described
(Wang et al., 2003a; 2003b; Liu et al., 2004; Peng et al., 2006, see also
Extended Experimental Procedures). Slices in the recording chamber were
continuously superfused with artificial cerebrospinal fluid (ACSF, 2 ml/min)
saturated with 95%O2/5%CO2 at 30 ± 1
C. The composition of ACSF (in mM)
was 124 NaCl, 3 KCl, 1.25 NaH2PO4, 1.2 MgCl2, 2 CaCl2, 26 NaHCO3, and 10
dextrose.
Co-IP, Affinity Binding Assay, and Western Blots
Cerebral cortex was homogenized in ice-cold lysis buffer containing (mM)
50 Tris-HCl, 150 NaCl, 1% NP-40, 2 EDTA, 1 Na-orthovanadate, (pH 7.4),
and proteinase inhibitor mixture (Sigma, 5 ml/100 mg tissue). After clearing
debris by centrifuging at 14,000 3 g at 4C, protein concentration in the
extracts was determined by Bradford assay (Bio-Rad, Hercules, CA). The
extracts (500 mg protein) were incubated with nonspecific IgG (2 mg) or poly-
clonal rabbit anti-NR2B (2 mg; Millipore) or anti-DAPK1 (2 mg, Sigma) overnight
at 4C, followed by the addition of 40 ml of Protein G-Sepharose (Sigma) for 3 hr
at 4C. The precipitates were washed four times with lysis buffer and dena-
tured with SDS sample buffer and separated by 12% SDS-PAGE. Proteins
were transferred onto nitrocellulose membranes using a Bio-Rad mini-
protein-III wet transfer unit overnight at 4C. Transfer membranes were then
incubated with blocking solution [5% nonfat dried milk dissolved in TBST
buffer containing (mM); 10 Tris-HCl, 150 NaCl, and 0.1% Tween-20 for 1 hr
at room temperature, washed three times, and incubated with anti-goat
primary antibody against NR1 (1:1000, Santa Cruz), anti-rabbit antibody
against NR2A (anti-NR2A, 1:1000; Millipore), NR2B (anti-NR2B, 1:1000; Milli-
pore), PSD-95 (anti-PSD-95, 1:1000; Santa Cruz), or anti-DAPK1 (1: 1000,
Sigma) for 1 hr at room temperature. Membranes were washed three times
with TBST buffer and incubated with the appropriate secondary antibodies
(1:1000 dilution) for 1 hr followed by washing four times. Signal detection
was performed with an enhanced chemiluminescence kit (Amersham Biosci-
ences, Arlington, IL). The lanes marked ‘‘input’’ were loaded with 10% of the
starting material used for immunoprecipitation.
To determine direct binding of DAPK1 with NMDA receptor NR2B
C-terminal domain, the GST-NR2B deletion mutants (GST-NR2B839-1482,
GST-NR2B839-1261, GST-NR2B1261-1292, GST-NR2B1292-1304, and GST-
NR2B1305-1482) were generated and purified. Purified GST fusion proteins
were separated on SDS-PAGE and transferred onto a nitrocellulose
membrane, which was washed with distilled water and blocked with TBST for
1 hr at room temperature. The membrane was then incubated with affinity
binding buffer containing 50 mM Tris-HCl, (pH 7.5), 200 mM NaCl, 12 mM
b-mercaptoethanol, 1.0% polyethylene glycol, 10 mg/ml protease inhibitors
and 500 mg/ml purified flag-taggedDAPK1 (Invitrogen) for 1 hr at room temper-
ature and washed four times for 5 min with affinity binding buffer. Bound
DAPK1 was detected with anti-Flag (1: 2000, Invitrogen).
Protein Identification
Protein bands were excised manually from the Coomassie blue-stained gels
and then digested automatically using a Proteineer DP protein digestion
station (Bruker-Daltonics, Bremen, Germany). Tryptic products were analyzed
using Nano-Liquid Chromatography-Tandem Mass Spectrometry (NLC/MS).
Each spectrum was internally calibrated with mass signals of trypsin autolysis
ions to reach a typical mass measurement accuracy of ± 10 ppm. Raw data
were searched in the SWISS-PROT database.
Cell Cultures and Oxygen-Glucose Deprivation
Hippocampi were isolated from the E20 DAPK1 mice. Cells were dissociated
and purified using papain dissociation kit (Worthington Biochemical Corpora-
tion) platted with the densities of 100–150 cells/mm for Ca2+ image or
800–1000 cells/mm for OGD on 19 mm coverslips coated with 30 mg/ml
poly-D-lysine and 2 mg/ml laminin. Cells were placed in fresh serum-free
Neurobasal Medium (21103, GIBCO) plus 2% B27 and fed every 4 days with
fresh media and used after 18 days (DIV18). Oxygen/glucose deprivation
(OGD) was induced by perfusion (2 ml/min) of a glucose-free bicarbonate-
buffer containing (in mM) 120 NaCl, 5 KCl, 2.0 CaCl2, 0.8 MgCl2, 25 NaHCO3,
(pH 7.4), at 32C, saturated with 5% CO2/10% H2/85%N2 for 0, 5, 15, or 30
min. Zero or 30 min after OGD washout, the cultures were used for enzymatic
assays. In all NMDA treatment, 10 mM glycine was included. The phosphory-
lated myosine light chain (MLC) at Thr-18 and Ser-18 (pMLC) that was cata-
lyzed by an activated DAPK1 in the lysates was blotted with anti-pMLC
(1:1000, Millipore) or anti-pDAPK1 (1:500, Millipore) that specifically recog-
nizes the phosphorylated DAPK1 at Ser-308. For measurement of phosphor-
ylation of the NMDA receptor NR2B subunit at Ser-1303 (pS1303), the NMDA
receptor complex was immunoprecipitated using anti-NR1. The precipitates
were then probed using anit-pS1303 (1:1000, anti-phospho-NR2B at Ser1303
with antigene: RRQHpSYDTF, Millipore). The bands were quantified using
‘‘the normalized method’’ of the densitometer Quantity One following the
Quantity One user instructions (Bio-Rad). The intensities of the bands marked
‘‘0’’ in each gel were normalized as 1. Each of the other bands in the same gel
was then normalized to ‘‘0’’ bands.
Ca2+ Imaging
For Ca2+ imaging, the neuronal cultures were loaded with fura-2-AM (1 mM,
Invitrogen) for 30 min followed by 5 washes for 30 min. The cultures were
then subjected to OGD for 30 min (OGD, pre-OGD-treated) or 0 min (control).
The 30 min OGD was chosen because it activates DAPK1 without causing
morphological changes, thereby ensuring accurate measurement of Ca2+
signals in single neurons. Immediately after OGD washout, the cultures were
perfused at 4 ml/min with a glucose-containing bicarbonate buffer 135 NaCl,
5 KCl, 2.0 CaCl2, 25 NaHCO3, and 10 glucose, (pH 7.4), at 32
C, saturated
with 5% CO2/10% H2/85%O2. Synaptic NMDA receptors were activated by
applying 30 mM bicuculline (Bic)/2 mM 4-AP in the presence of 10 mM nifedi-
pine. Onemin after Bic/4-AP, MK-801 (20 mM, Sigma) was applied for blocking
synaptic NMDA receptor channels. Since MK-801 is an irreversible open
channel blocker, activated synaptic NMDA receptor channels remained
blocked after MK-801 washout. To ensure these synaptic NMDA receptor
channels were not reactivated, we applied AMPA receptor antagonist CNQX
(10 mM) to block neuronal spontaneous firing. The extrasynaptic NMDA
receptors were activated by a 5 ms pulse of 100 mM NMDA/10 mM glycine
(Sigma) in the presence of 10 mMCNQX (Tocris) and 10 mMnifendipine (Sigma).
One min later 10 mM ifenprodil was applied using SmartSquirt 4-Micro-Perfu-
sion System with ValveLink8.2 controller (AutoMate Scientific, Berkeley, CA).
Fura-2 340 and 380 nm fluorescence imaging pairs were collected through
an AxioCam MRM REV3 camera, which was equipped with an Axio Observer
200microscopewith a 633 Fluor water immersion objective. The imageswerecaptured with 30 cycles/second using Axiovision 4.7 software in Carl Zeiss
Imaging Station 35A with XP Pro. Calcium concentrations were expressed
as a function of the [Ca2+]/Kd = [(F-Fmin)/(Fmax-F)]. The average values that
were normalized to basal line (defined as 1.0) were determined for each 20 s
period of measurement (60 images).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
three figures, and two tables and can be found with this article online at
doi:10.1016/j.cell.2009.12.055.
ACKNOWLEDGMENTS
This work was supported by the American Heart Association (05553413YL;
0535201YC; and 0625532 XZ), National Institute of Health (NIH/NINDS,
R01NS5051383YL and NIH/NIA R01AG033282YL). We thank Ryan Labadens
at the Neuroscience Center of Excellence, Louisiana State University School of
Medicine Health Sciences Center, and for assistance in manuscript prepara-
tion and discussion.
Received: December 12, 2008
Revised: October 16, 2009
Accepted: December 29, 2009
Published: January 21, 2010
REFERENCES
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J.W., Wang, Y.T.,
Salter, M.W., and Tymianski, M. (2002). Treatment of ischemic brain damage
by perturbing NMDA receptor- PSD-95 protein interactions. Science 298,
846–850.
Aarts, M., Iihara, K., Wei, W.L., Xiong, Z.G., Arundine, M., Cerwinski, W., Mac-
Donald, J.F., and Tymianski, M. (2003). A key role for TRPM7 channels in
anoxic neuronal death. Cell 115, 863–877.
Bano, D., Young, K.W., Guerin, C.J., Lefeuvre, R., Rothwell, N.J., Naldini, L.,
Rizzuto, R., Carafoli, E., and Nicotera, P. (2005). Cleavage of the plasma
membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 120, 275–285.
Bialik, S., and Kimchi, A. (2006). The Death-Associated Protein Kinases: Struc-
ture, Function, and Beyond. Annu. Rev. Biochem. 75, 189–200.
Brickley, S.G., Misra, C., Mok, M.H., Mishina, M., and Cull-Candy, S.G. (2003).
NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form
a distinct NMDA receptor subtype restricted to extrasynaptic sites. J. Neuro-
sci. 23, 4958–4966.
Chatterton, J.E., Awobuluyi, M., Premkumar, L.S., Takahashi, H., Talantova,
M., Shin, Y., Cui, J., Tu, S., Sevarino, K.A., Nakanishi, N., et al. (2002). Excit-
atory glycine receptors containing the NR3 family of NMDA receptor subunits.
Nature 415, 793–798.
Drejer, J., Benveniste, H., Diemer, N.H., and Schousboe, A. (1985). Cellular
origin of ischemia-induced glutamate release from brain tissue in vivo and
in vitro. J. Neurochem. 45, 145–151.
Eliasson, M.J., Huang, Z., Ferrante, R.J., Sasamata, M., Molliver, M.E.,
Snyder, S.H., andMoskowitz, M.A. (1999). Neuronal nitric oxide synthase acti-
vation and peroxynitrite formation in ischemic stroke linked to neural damage.
J. Neurosci. 19, 5910–5918.
El-Husseini, Ael-D., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q., Prange, O.,
Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll, R.A., and Bredt, D.S.
(2002). Synaptic strength regulated by palmitate cycling on PSD-95. Cell
108, 849–863.
Finkbeiner, S. (2000). CREB couples neurotrophin signals to survival
messages. Neuron 25, 11–14.
Fiskum, G., Murphy, A.N., and Beal, M.F. (1999). Mitochondria in neurodegen-
eration: acute ischemia and chronic neurodegenerative diseases. J. Cereb.
Blood Flow Metab. 19, 351–369.Cell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc. 233
Gardoni, F., Bellone, C., Viviani, B., Marinovich, M., Meli, E., Pellegrini-Giam-
pietro, D.E., Cattabeni, F., and Di Luca, M. (2002). Lack of PSD-95 drives
hippocampal neuronal cell death through activation of an alpha CaMKII trans-
duction pathway. Eur. J. Neurosci. 16, 777–786.
Ghosh, A. (2002). Neurobiology. Learning more about NMDA receptor regula-
tion. Science 295, 449–451.
Greengard, P. (2001). The neurobiology of slow synaptic transmission.
Science 294, 1024–1030.
Hanson, S.K., Grotta, J.C., Waxham, M.N., Aronowski, J., and Ostrow, P.
(1994). Calcium/calmodulin-dependent protein kinase II activity in ischemia
with reperfusion in rats. Stroke 25, 466–473.
Hardingham, G.E., Fukunaga, Y., and Bading, H. (2002). Extrasynaptic
NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell
death pathways. Nat. Neurosci. 5, 405–414.
Khanna, S., Roy, S., Park, H.A., and Sen, C.K. (2007). Regulation of c-Src
activity in glutamate-induced neurodegeneration. J. Biol. Chem. 282, 23482–
23490.
Kinouchi, H., Epstein, C.J., Mizui, T., Carlson, E., Chen, S.F., and Chan, P.H.
(1991). Attenuation of focal cerebral ischemic injury in transgenic mice overex-
pressing CuZn superoxide dismutase. Proc. Natl. Acad. Sci. USA 88, 11158–
11162.
Krupp, J.J., Vissel, B., Thomas, C.G., Heinemann, S.F., and Westbrook, G.L.
(1999). Interactions of calmodulin and a-actinin with the NR1 subunit modulate
Ca2+-dependent inactivation of NMDA receptors. J. Neurosci. 19, 1165–1178.
Krajewski, S., Krajewska, M., Ellerby, L.M., Welsh, K., Xie, Z., Deveraux, Q.L.,
Salvesen, G.S., Bredesen, D.E., Rosenthal, R.E., Fiskum, G., and Reed, J.C.
(1999). Release of caspase-9 from mitochondria during neuronal apoptosis
and cerebral ischemia. Proc. Natl. Acad. Sci. USA 96, 5752–5757.
Lipton, S.A. (2006). Paradigm shift in neuroprotection by NMDA receptor
blockade: memantine and beyond. Nat. Rev. Discov. 5, 160–170.
Liu, L., Lau, L., Zhu, D.Y., Wei, J.S., Zou, S., Sun, H.S., Fu, Y.P., Liu, F., and Lu,
Y. (2004). Expression of Ca2+-permeable AMPA receptor channels primes cell
death in transient forebrain ischemia. Neuron 43, 43–55.
Liu, Y., Wong, T.P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T.W., Wu, D.C., Lu,
J., Tymianski, M., Craig, A.M., andWang, Y.T. (2007). NMDA receptor subunits
have differential roles in mediating excitotoxic neuronal death both in vitro and
in vivo. J. Neurosci. 27, 2846–2857.
Lisman, J., Schulman, H., and Cline, H. (2002). The molecular basis of CaMKII
function in synaptic and behavioural memory. Nat. Rev. Neurosci. 3, 175–190.
Lo, E.H., Dalkara, T., and Moskowitz, M.A. (2003). Mechanisms, challenges
and opportunities in stroke. Nat. Rev. Neurosci. 4, 399–415.
Mabuchi, T., Kitagawa, K., Kuwabara, K., Takasawa, K., Ohtsuki, T., Xia, Z.,
Storm, D., Yanagihara, T., Hori, M., and Matsumoto, M. (2001). Phosphoryla-
tion of cAMP response element-binding protein in hippocampal neurons as
a protective response after exposure to glutamate in vitro and ischemia
in vivo. J. Neurosci. 21, 9204–9213.
Madden, D.R. (2002). The structure and function of glutamate receptor ion
channels. Nat. Rev. Neurosci. 3, 91–101.
Marshall, J., Dolan, B.M., Garcia, E.P., Sathe, S., Tang, X., Mao, Z., and Blair,
L.A. (2003). Calcium channel and NMDA receptor activities differentially
regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron 39,
625–639.
Omkumar, R.V., Kiely, M.J., Rosenstein, A.J., Min, K.T., and Kennedy, M.B.
(1996). Identification of a phosphorylation site for calcium/calmodulindepend-
ent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor.
J. Biol. Chem. 271, 31670–31678.
Pellegrini-Giampietro, D.E., Gorter, J.A., Bennett, M.V., and Zukin, R.S. (1997).
The GluR2 (GluRB) hypothesis: Ca2+-permeable AMPA receptors in neurolog-
ical disorders. Trends Neurosci. 20, 464–470.
Peng, P.L., Zhong, X.F., Tu, W.H., Soundarapandian, M.M., Molner, P., Zhu,
D.Y., Liu, S.H., and Lu, Y. (2006). ADAR2-Dependent RNA Editing of AMPA
Receptor Subunit GluR2 Determines Vulnerability of Neurons in Forebrain
Ischemia. Neuron 49, 719–733.234 Cell 140, 222–234, January 22, 2010 ª2010 Elsevier Inc.Petersen, J.D., Chen, X., Vinade, L., Dosemeci, A., Lisman, J.E., and Reese,
T.S. (2003). Distribution of postsynaptic density (PSD)-95 and Ca2+/calmod-
ulin-dependent protein kinase II at the PSD. J. Neurosci. 23, 11270–11278.
Rossi, D.J., Oshima, T., and Attwell, D. (2000). Glutamate release in severe
brain ischemia is mainly by reversed uptake. Nature 403, 316–321.
Salter, M.W., and Kalia, L.V. (2004). Src kinases: a hub for NMDA receptor
regulation. Nat. Rev. Neurosci. 5, 317–328.
Schumacher, A.M., and Schavocky, J.P. (2004). Velentza, A. V., Mirzoeva, S. &
Waterson, D. M. A calmodulin-regulated protein kinase linked to neuron
survival is a substrate for the calmodulin-regulated death-associated protein
kinase. Biochemistry 43, 8116–8124.
Simon, R.P., Swan, J.H., and Meldrum, B.S. (1984). Blockade of N-methyl-D-
aspartate receptors may protect against ischemic damage in the brain.
Science 226, 850–852.
Simpkins, K.L., Guttmann, R.P., Dong, Y., Chen, Z., Sokol, S., Neumar, R.W.,
and Lynch, D.R. (2003). Selective activation induced cleavage of the NR2B
subunit by calpain. J. Neurosci. 23, 11322–11331.
Shohat, G., Spivak-Kroizman, T., Cohen, O., Bialik, S., Shani, G., Berrisi, H.,
Eisenstein, M., and Kimchi, A. (2001). The pro-apoptotic function of death-
associated protein kinase is controlled by a unique inhibitory autophosphory-
lation-based mechanism. J. Biol. Chem. 276, 47460–47467.
Sprengel, R., Suchanek, B., Amico, C., Brusa, R., Burnashev, N., Rozov, A.,
Hvalby, O., Jensen, V., Paulsen, O., Andersen, P., et al. (1998). Importance
of the intracellular domain of NR2 subunits for NMDA receptor function
in vivo. Cell 92, 279–289.
Sun, M.K., Hongpaisan, J., Nelson, T.J., and Alkon, D.L. (2008). Poststroke
neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in
adult brains. Proc. Natl. Acad. Sci. USA 105, 13620–13625.
Takasu, M.A., Dalva, M.B., Zigmond, R.E., and Greenberg, M.E. (2002). Modu-
lation of NMDA receptor-dependent calcium influx and gene expression
through EphB receptors. Science 295, 491–495.
Thomas, C.G., Miller, A.J., and Westbrook, G.L. (2006). Synaptic and extrasy-
naptic NMDA receptor NR2 subunits in cultured hippocampal neurons. J. Neu-
rophysiol. 95, 1727–1734.
Tovar, K.R., andWestbrook, G.L. (1999). The incorporation of NMDA receptors
with a distinct subunit composition at nascent hippocampal synapses in vitro.
J. Neurosci. 19, 4180–4188.
Uehara, T., Nakamura, T., Yao, D., Shi, Z.Q., Gu, Z., Ma, Y., Masliah, E.,
Nomura, Y., and Lipton, S.A. (2006). S-nitrosylated protein-disulphide isom-
erase links protein misfolding to neurodegeneration. Nature 441, 513–517.
Van Eldik, L.J. (2002). Structure and enzymology of a death-associated protein
kinase. Trends Pharmacol. Sci. 23, 302–304.
Velentza, A.V., Schumacher, A.M., Weiss, C., Egli, M., and Watterson, D.M.
(2001). A protein kinase associated with apoptosis and tumor suppression:
structure, activity, and discovery of peptide substrates. J. Biol. Chem. 276,
38956–38965.
Wang, J., Liu, S.H., Fu, Y.P., Wang, J.H., and Lu, Y. (2003a). Cdk5 activation
induces CA1 pyramidal cell death by direct phosphorylation of NMDA recep-
tors. Nat. Neurosci. 6, 1039–1047.
Wang, J., Liu, S., Haditsch, U., Tu, W., Cochrane, K., Ahmadian, G., Tran, L.,
Paw, J., Wang, Y., Mansuy, I., et al. (2003b). Interaction of calcineurin and
type-A GABA receptor gamma 2 subunits produces long-term depression at
CA1 inhibitory synapses. J. Neurosci. 23, 826–836.
Wang, H.G., Pathan, N., Ethell, I.M., Krajewski, S., Yamaguchi, Y., Shibasaki, F.,
McKeon, F., Bobo, T., Franke, T.F., and Reed, J.C. (1999). Ca2+-induced
apoptosis throughcalcineurindephosphorylationofBAD.Science284, 339–343.
Waxham, M.N., Grotta, J.C., Silva, A.J., Strong, R., and Aronowski, J. (1996).
Ischemia-induced neuronal damage: a role for calcium/calmodulin-dependent
protein kinase II. J. Cereb. Blood Flow Metab. 16, 1–6.
Xiong, Z.G., Zhu, X.M., Chu, X.P., Minami, M., Hey, J., Wei, W.L., MacDonald,
J.F., Wemmie, J.A., Price, M.P., Welsh, M.J., and Simon, R.P. (2004). Neuro-
protection in ischemia: blocking calcium-permeable acid-sensing ion chan-
nels. Cell 118, 687–698.
